Biosensors bridge biology and measurement, using biological components to detect specific analytes and convert their presence into quantifiable signals. In the synthetic biology context, biosensors can be either cell-based (living engineered organisms that glow, change color, or produce an electrical signal when they detect a target molecule) or cell-free (using extracted biological components on a test strip or in a device). The glucose monitors used by millions of diabetics are the most commercially successful biosensors, generating a multi-billion-dollar market.
Synthetic biology is dramatically expanding the range of analytes that biosensors can detect. Engineered bacteria have been designed to detect environmental pollutants (arsenic, mercury, lead), disease biomarkers (gut inflammation markers for Synlogic's therapeutic applications), explosives (TNT), and pathogens. Cell-free biosensors, particularly those developed by researchers like James Collins at MIT, can be freeze-dried onto paper strips, stored at room temperature, and activated by adding a drop of sample — making them ideal for field diagnostics in resource-limited settings.
The convergence of biosensors with wearable technology and continuous monitoring is an emerging frontier. Companies are developing biosensor platforms that can be integrated into patches, clothing, or implantable devices for real-time health monitoring. Engineered genetic circuits enable biosensors with tunable sensitivity, multi-analyte detection, and digital (on/off) or analog (dose-dependent) readouts. As the cost and complexity of biosensor development decrease through synthetic biology tools, the technology is expanding from laboratory instruments into consumer health, environmental monitoring, and food safety applications. For deeper coverage, see SynBioIntel.